KYTX Key Metrics | Stock Alarm Pro

Sign In Create Free Alerts

Kyverna Therapeutics, Inc.KYTXNASDAQ

Loading

Overview Intelligence Charts Fundamentals Key Metrics Earnings Growth Financials Insiders

Key Metrics

As of 2024• vs 2023

Core Metrics

Market Cap

$143.37M-99.3%

-81.23%-30853.1%

Interest Coverage

-1004.25x-200.9%

Per Share

Revenue/Share

$0.00

Net Income/Share

$-3.33-3610.8%

Operating CF/Share

$-2.98-3730.6%

Free CF/Share

$-3.04-3758.8%

Cash/Share

$7.46+8633.1%

Book Value/Share

$6.95+9425.8%

Tangible Book/Share

$6.95+9425.8%

Equity/Share

$6.95+9425.8%

Interest Debt/Share

$0.22+1490.0%

Valuation

Market Cap

$143.37M-99.3%

Enterprise Value

$54.99M-99.7%

P/OCF Ratio

-1.25+99.7%

P/FCF Ratio

-1.23+99.7%

P/TB Ratio

0.54-99.9%

EV/EBITDA

-0.44+99.9%

Profitability

-88.91%-29665.6%

-81.23%-30853.1%

Return on Tangible Assets

Capital Allocation

CapEx/OCF

-1.93%-62.9%

CapEx/Revenue

0.00%

CapEx/Depreciation

1.03+184.2%

SBC/Revenue

0.00%

Balance Sheet

Net Debt/EBITDA

0.71+61.4%

Interest Coverage

-1004.25x-200.9%

Efficiency

Days Sales Outstanding

0 days

Days Payables Outstanding

791 days-15.1%

Days Inventory

0 days

Receivables Turnover

0.00x

Payables Turnover

0.46x+17.8%

Inventory Turnover

0.00x

Special Valuations

Graham Number

--

Graham Net-Net

$6.47+13719.2%

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance